Ever Source Wealth Advisors, LLC Elevation Oncology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 56 shares of ELEV stock, worth $20. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 19
194.74%
Holding current value
$20
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
62Shares Held
30.6MCall Options Held
50KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$2.16 Million0.12% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.89MShares$2.12 Million1.64% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.02 Million0.29% of portfolio
-
Black Rock Inc. New York, NY2.49MShares$896,4890.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.26MShares$812,4080.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $8.39M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...